SCHEMBL8544707

SCHEMBL8544707

Cn1c(=O)c(C(=O)O)c(-c2ccccc2Cl)c2cc(Cl)ccc21

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.47
EGFR P00533 1/20 0.46
MEN1 O00255 5/20 0.44
KDM4E B2RXH2 2/20 0.44
IKBKB O14920 1/20 0.44
CHUK O15111 1/20 0.44
AKT1 P31749 1/20 0.44
AKT2 P31751 1/20 0.44
AKT3 Q9Y243 1/20 0.44
CHEK1 O14757 1/20 0.43
WEE1 P30291 1/20 0.43
DNMT1 P26358 3/20 0.43
GSK3B P49841 2/20 0.41
TP53 P04637 1/20 0.40
MAPT P10636 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
FABP3 P05413 1/20 0.40
FABP4 P15090 1/20 0.40
NPC1 O15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9363440 0.89 KMT2A (0.46) KMT2AEGFRMEN1KDM4EIKBKB
SCHEMBL27337810 0.88 KMT2A (0.46) KMT2AEGFRMEN1KDM4EIKBKB
SCHEMBL9358757 0.86 EDNRB (0.42) KMT2AMEN1KDM4ECHEK1WEE1
SCHEMBL9358984 0.86 KDM4E (0.41) KMT2AMEN1KDM4ECHEK1WEE1
SCHEMBL8784716 0.86 IKBKB (0.55) KMT2AEGFRIKBKBCHUKAKT1
SCHEMBL9358730 0.85 LMNA (0.44) KMT2AMEN1WEE1NPC1
SCHEMBL8784656 0.84 ALDH1A1 (0.54) KMT2AMEN1KDM4EMAPTSMN1; SMN2
SCHEMBL8543014 0.81 KDM4E (0.44) KMT2AEGFRMEN1KDM4ECHEK1
SCHEMBL6636719 0.80 ROCK2 (0.43) KMT2AMEN1WEE1SMN1; SMN2NPC1
SCHEMBL27396929 0.78 EGFR (0.54) KMT2AEGFRMEN1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0623112-B1 4-Phenyl-3-(heteroarylureido)-1,2-dihydro-2-oxoquinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents PFIZER (US) 1998-12-30 EP disclosed
US-5565472-A 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents PFIZER INC. (US) 1996-10-15 US disclosed
EP-0421456-B1 Quinoline derivatives, their production and use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1994-12-28 EP disclosed
EP-0623112-A1 4-ARYL-3-(HETEROARYLUREIDO)-1,2-DIHYDRO-2-OXO-QUINOLINE DERIVATIVES AS ANTIHYPERCHOLESTEROLEMIC AND ANTIATHEROSCLEROTIC AGENTS PFIZER INC. (US) 1994-11-09 EP disclosed
WO-1993015058-A1 4-ARYL-3-(HETEROARYLUREIDO)-1,2-DIHYDRO-2-OXO-QUINOLINE DERIVATIVES AS ANTIHYPERCHOLESTEROLEMIC AND ANTIATHEROSCLEROTIC AGENTS PFIZER INC. (US) 1993-08-05 WO disclosed
US-5223513-A Anticholesterol agent TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-06-29 US disclosed
EP-0421456-A2 Quinoline derivatives, their production and use Takeda Chemical Industries, Ltd. (JP) 1991-04-10 EP disclosed